NervGen Pharma Corp. (NGEN)

NervGen Pharma Corp. (NGEN $3.55)
- $3.55 Cap: $259M
- View NGEN Profile
- View Questions on NGEN

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

NervGen Pharma Corp. (NGEN $3.55)
- $3.55 Cap: $259M
- View NGEN Profile
- View Questions on NGEN

Q: Can I get your assessment of NGEN? Can the fundamentals support a sustained move in this one? That is some major volume coming in on those up days! Thanks.

Read Answer Asked by Philip on May 22, 2025